India is currently facing the silent epidemic of metabolic syndrome. Its presence predicts high morbidity and mortality from cardiovascular diseases, diabetes and stroke. Attempts to control its ill effect with life style measures, statin and rimonabant, a selective cannabinoid -1 receptor (CB 1 ) blocker, are currently under vogue. The enormity of the problem and cost considerations of statin and/ or rimonabant therapy compels us to look for the alternative strategy. Medicinal plants have been found to correct endothelial dysfunction, dyslipidemia, dysglycemia, coagulation abnormalities, and have immunomodulating properties. As metabolic syndrome is characterized by above cluster of abnormalities; it would only be appropriate to explore the utility of those plants reputed with hypoglycemic, hypolipidemic, immunomodulating, and anti-inflammatory activities. RR1, tinosporaside, cardioside, columbin,, and Zingiber officinale Roscoe Qleoresin -6-gingeroi (1-4-hydroxy-3-methoxyphenyl-5 hydroxy-3 decanone), 8-gingerol, 10-gingerol, 6 shogaol). The respective bioactive constituents of each plant have been mentioned in the accompanying bracket. Individual properties and clinico-biochemical implications will be discussed. One of the essential components of drug therapy with the botanical preparations is the implementation of other life style measures like cessation of smoking / tobacco, exercise regimen, and low fat, low salt; high fiber diet. 1990, 1991, 1992, 1996, 1999 Vaccination with an adjuvant has demonstrated to be a suitable strategy for protection against many infectious diseases; however this approach is dependent on an effective adjuvant inducing the desired immune response. Although we may think that we understand how vaccine adjuvants work, we cannot satisfactorily explain why certain vaccine adjuvants and/or delivery systems are more or less effective at inducing immune responses, or why they promote the induction of particular types of response. In the present study, DIPAS has developed a new herbal adjuvant -DIP-HIP, and compared its efficacy with two widely used adjuvants viz. Complete Freund's Adjuvant (CFA), and Alum. The dynamic changes in the humoral immune response were measured in terms of serum antibody titers and cell mediated immune response in terms of cell proliferation, antibody isotypes and cytokine profile. Animals were immunized with different antigens like native proteins, recombinant and fusion proteins etc. The adjuvanticity was also tested in different strains and species of animals using different immunization schedules and routes (i.m./ i.p.). The shelf life and batch variation was determined at various temperatures and time periods. The observations indicated that DIP-HIP was at par with CFA and better than alum. There was a significant enhancement of antigen specific antibody levels on administration of DIP-HIP. The cytokine profile correlated very well with the Th1 and Th2 type of immune response. The sustenance of antibody response in the body persisted for more than four months. Using animals of different strains and species, interestingly, DIP-HIP displayed characteristics better than CFA. Immunization through different routes did not cause any change or muscular damage or dystrophy. The shelf life of DIP-HIP at 4 o C was evaluated for more than two years without any difference. Distinct batches of DIP-HIP collected at different times, places under different environmental conditions did not show any batch to batch variation. The enhancing effects of DIP-HIP on these antigen specific-antibody responses in animals were almost similar to oil adjuvant but more significant than that of alum. This herbal adjuvant can effectively substitute for oil and alum adjuvants.
To develop a new microbicide agent in the form of gel, cream, film or suppository, which possess contraceptive efficacy, for addressing the women's need and perspective. NIM-76, the active ingredient of 'CONCEPT' inhibited the growth of the general pathogenic bacteria (Escherichia coli, Proteus mirabilis, Salmonella typhi and Staphylococcus aureus) and fungi (Aspergillus flavus, Aspergillus fumigatus, Mucor sp., Penicillium sp. and Rhizopus sp.. NIM-76 was inhibitory to bacteria Neiseria gonorrhoea. The protozoan, Trichmonas vaginalis and the fungus associated with sexually transmitted infections, Candida albicans were also inhibited by NIM-76. Further studies showed its ability to bind to the Hepatitis B surface antigen and its inhibitory activity against HBV DNA polymerase and reverse transcriptase of Herpes simplex virus-2 and Human immunodeficiency virus. The formulation was also able to inhibit general proteases viz. a-chymotripsin, leucine amino peptidase and papain. NIM-76 also possesses spermicidal activity when tested in-vitro and prevent fertility on pre-coital application in experimental animals. The formulation in the form of pessary has undergone Phase I Clinical trials after obtaining clearance from the Drug Controller of India. 'CONCEPT a neem based vaginal contraceptive developed by Defence Institute of Physiology and Allied Sciences in collaboration with Indian Agricultural Research Institute possesses anti-microbial activities against a wide range of pathogenic organisms and thus seems to have the potentials of a microbicide of choice as it has both anti-microbial and contraceptive activities.
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